OTC Statin Target Population Receives Significant FDA Attention
This article was originally published in The Tan Sheet
Executive Summary
The type of people most suited for OTC statin therapy received considerable attention from FDA during the agency's discussion on the OTC availability of vascular drugs at a public meeting in Gaithersburg, Md. June 28-29.